Schnyder C C, Shaarawy T, Ravinet E, Achache F, Uffer S, Mermoud A
Glaucoma Unit, Hopital Ophtalmique Jules Gonin, University of Lausanne, Switzerland.
J Glaucoma. 2002 Feb;11(1):10-6. doi: 10.1097/00061198-200202000-00003.
To describe methods and outcomes of excisional revision of a filtering bleb (bleb revision) using free conjunctival autologous graft either for bleb repair or for bleb reduction after trabeculectomy and deep sclerectomy with an implant.
Retrospective medical records were reviewed for a consecutive non-comparative case series comprising patients who underwent excisional revision of a filtering bleb between May 1998-January 2001. Excisional revision using free conjunctival autologous graft (bleb revision) was performed either for bleb repair, to treat early and late leaks and hypotony with maculopathy, or for bleb reduction, to improve ocular pain, discomfort, burning, foreign body sensation, tearing, and fluctuations of visual acuity. The revision consisted of bleb excision and free conjunctival autologous graft. The bleb histopathology was analyzed in patients who underwent bleb repair.
Sixteen patients were included in the study, consisting of nine patients who had a trabeculectomy and seven patients who had a deep sclerectomy with an implant. Bleb revision was necessary in 14 patients due to leaking filtering bleb (bleb repair), and in 2 patients due to bleb dysesthesia (bleb reduction). After a follow-up of 15.1 +/- 8.4 months, the mean intraocular pressure (IOP) rose from 7.8 +/- 6.3 mm Hg to 14.3 +/- 6.5 mm Hg, and the visual acuity from 0.4 +/- 0.3 to 0.7 +/- 0.3, with a P value of 0.008 and 0.03, respectively. The complete success rate at 32 months, according to the Kaplan-Meier survival curve, was 38.3%, and the qualified success rate was 83.3%. Four patients (25%) required additional suturing for persistent bleb leak. To control IOP, antiglaucoma medical therapy was needed for six patients (37.5%) and repeated glaucoma surgery was needed for one patient.
Free conjunctival autologous graft is a safe and successful procedure for bleb repair and bleb reduction. However, patients should be aware of the postoperative possibility of requiring medical or surgical intervention for IOP control after revision.
描述使用游离自体结膜移植片进行滤过泡切除性修复(滤过泡修复)的方法和结果,该方法用于小梁切除术和带植入物的深层巩膜切除术后的滤过泡修复或滤过泡缩小。
回顾了1998年5月至2001年1月间连续非对照病例系列的回顾性病历,这些患者接受了滤过泡切除性修复。使用游离自体结膜移植片进行滤过泡切除性修复(滤过泡修复),目的是修复滤过泡,治疗早期和晚期渗漏以及伴有黄斑病变的低眼压,或缩小滤过泡,以改善眼痛、不适、烧灼感、异物感、流泪和视力波动。修复包括滤过泡切除和游离自体结膜移植。对接受滤过泡修复的患者进行滤过泡组织病理学分析。
16例患者纳入研究,其中9例行小梁切除术,7例行带植入物的深层巩膜切除术。14例患者因滤过泡渗漏需要进行滤过泡修复,2例患者因滤过泡感觉异常需要进行滤过泡缩小。随访15.1±8.4个月后,平均眼压从7.8±6.3mmHg升至14.3±6.5mmHg,视力从0.4±0.3提高到0.7±0.3,P值分别为0.(此处原文有误,推测应为0.008)和0.03。根据Kaplan-Meier生存曲线,32个月时的完全成功率为38.3%,合格成功率为83.3%。4例患者(25%)因滤过泡持续渗漏需要额外缝合。为控制眼压,6例患者(37.5%)需要抗青光眼药物治疗,1例患者需要再次进行青光眼手术。
游离自体结膜移植片是一种安全且成功的滤过泡修复和滤过泡缩小手术。然而,患者应意识到修复术后可能需要药物或手术干预来控制眼压。